From Northern Europe to The South Atlantic - Over 1000 Kids In My Ocean Challenge Event
ESMO Deep Dive: Lung Cancer - Advanced NSCLC - Non-oncogene Addicted 2025
Five-Year Data Support Pembro + CRT for NSCLC
(PDF) Afatinib as first-line treatment in patients with EGFR -mutated non-small cell lung cancer in routine clinical practice
Biomarkers predict effectiveness of dupilumab treatment for moderate to severe asthma
Stringent medical risk management
RNA-seq–based profiling of extracellular vesicles in plasma reveals a potential role of miR-122-5p in asthma
Dr. Reck Discusses Prognostic and Predictive Factors for OS With Necitumumab in NSCLC
Velocity expands to 17 sites in Europe
Dr. Martin Reck Discusses Lung Cancer Highlights at Upcoming ESMO Congress
2025 1st Bundesliga Results
Hummingbird Diagnostics Announces Publication of miLung Small RNA-Based Blood Test for Early Detection of Lung Cancer in the Journal of Thoracic Oncology
Neoscan debuts MRI scanner for babies
NSCLC Phase 3 Trial Shows Triple Combo Improved Progression-Free Survival
Small‐scale genetic structure and mating patterns in an extensive sessile oak forest (Quercus petraea (Matt.) Liebl.)
Itepekimab lowers exacerbation rate in former smokers with COPD
Dupilumab improves long-term outcomes in patients with uncontrolled, moderate-to-severe GINA-based type 2 asthma, irrespective of allergic status
Identification of extracellular vesicle microRNA signatures specifically linked to inflammatory and metabolic mechanisms in obesity-associated low type-2 asthma
"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC | Libero Quotidiano.it